
Carl Asche
· Research ProfessorUniversity of Utah · College of Social Work
Active 1991–2025
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Carl Asche, MBA, MSc, PhD, is a Research Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy in Salt Lake City. He serves as the Executive Director of the Pharmacotherapy Outcomes Research Center (PORC) within the college and also directs the Post-Doctoral Fellowship Program in the Department of Pharmacotherapy. Additionally, he holds appointments as a Research Service WOC employee at the Veteran's Affairs Salt Lake City Healthcare System and as an Associate Member of the Cancer Control and Population Science Research Program at the Huntsman Cancer Institute. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. Dr. Asche has authored and co-authored over 150 peer-reviewed publications in medical and economic literature. His current research is funded by various federal agencies and pharmaceutical companies. He earned his PhD in Economics from the University of Surrey, MSc in Health Economics from the University of York, and MBA from the City University of Seattle. Dr. Asche is actively involved in teaching, serving as a lecturer for courses such as Cost-Effectiveness and Validation of Economic Models, and participates in numerous national and international health economics-focused boards and committees.
Research topics
- Computer Science
- Risk analysis (engineering)
- Nursing
- Economic growth
- Medicine
- Economics
- Data science
- Internal medicine
- Business
Selected publications
Clinical Nutrition · 2024-06-03 · 43 citations
reviewValue in Health · 2024-04-01 · 20 citations
articleClinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review
Ophthalmology and Therapy · 2025-02-26 · 17 citations
reviewOpen accessRetinal diseases, such as neovascular age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion, pose a significant global burden on individuals, families, and healthcare systems. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has become the standard treatment for retinal diseases, improving clinical outcomes, while delaying disease progression. Although effective, biologics are associated with high costs, which can lead to underutilisation and,…
Pharmacy Closures and Anticonvulsant Medication Prescription Fills
JAMA · 2024-11-04 · 8 citations
articleOpen accessThis study examines the relationship between pharmacy closures and anticonvulsant prescription fills and number of days supplied.
PD45 Paying For Digital Health: What Evidence Is Needed?
International Journal of Technology Assessment in Health Care · 2022-12-01 · 6 citations
articleOpen accessSenior authorIntroduction Digital transformation has been promoted by the World Health Organization (WHO), Food and Drug Administration (FDA) and the European Commission (EC) to help improve health outcomes. To ensure sustainability, digital health interventions (DHI) require funding by payers. Evidence-informed decision and policy making requires an assessment of the impact on relevant outcomes vs current healthcare practice. Various national and international organizations are involved in creating or guidi…
Frequent coauthors
- 179 shared
Jinma Ren
Statistical Research (United States)
- 94 shared
Carmen S. Kirkness
University of Illinois Urbana-Champaign
- 82 shared
Brian Seal
- 41 shared
William Tillis
- 38 shared
Zsombor Zrubka
Obuda University
- 38 shared
Minchul Kim
- 36 shared
Anita Burrell
Burrell Behavioral Health
- 31 shared
Kenneth M. Shermock
Johns Hopkins University
Labs
Education
Ph.D.
University of Su
Awards & honors
- 2022 International Society of Pharmacoeconomics and Outcomes…
Similar researchers at University of Utah
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Carl Asche
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
